Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls

Journal of Investigative Dermatology

Volumn 130, Issue 3, 2010, Pages 841-848

  Michael, Kristina M ^a   Waterboer, Tim ^a   Pfister, Herbert ^b   Gariglio, Marisa ^c   Majewski, Slawomir ^d   Favre, Michel ^e   Pawlita, Michael ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Amedeo Avogadro University   (Italy)

^d MEDICAL UNIVERSITY OF WARSAW   (Poland)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADOLESCENT; ADULT; AGED; ALPHAPAPILLOMAVIRUS; ARTICLE; BETAPAPILLOMAVIRUS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMODYSPLASIA VERRUCIFORMIS; ETHNICITY; FEMALE; GAMMAPAPILLOMAVIRUS; HETEROZYGOSITY; HUMAN; IMMUNOREACTIVITY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY; SEROPREVALENCE; VIRUS LOAD;

EID: 76649135496     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.356     Document Type: Article

References (47)

1. Azzimonti B, Mondini M, De Andrea M et al. (2005) CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Derma-tol 141:1323-1325
2. Casabonne D, Michael KM, Waterboer T et al. (2007) A prospective pilot study of antibodies against human papillomaviruses and cutaneous squamous cell carcinoma nested in the Oxford component of the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 121:1862-1868
3. Chen Z, Schiffman M, Herrero R et al. (2007) Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses. Virology 360:447-453
4. Dang C, Koehler A, Forschner T et al. (2006) E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients. Br J Dermatol 155:129-136
5. de Villiers EM, Fauquet C, Broker TR et al. (2004) Classification of papillomaviruses. Virology 324:17-27
6. Dell'Oste V, Azzimonti B, De Andrea M et al. (2009) High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 129:1026-1034
7. Dillner J (1999) The serological response to papillomaviruses. Semin Cancer Biol 9:423-430
8. Favre M, Majewski S, De Jesus N et al. (1998a) A possible vertical transmission of human papillomavirus genotypes associated with epidermodysplasia verruciformis. J Invest Dermatol 111:333-336 (Pubitemid 28354725)
9. Favre M, Orth G, Majewski S et al. (1998b) Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 110:311-317
10. Forslund O (2007) Genetic diversity of cutaneous human papillomaviruses. J Gen Virol 88:2662-2669 (Pubitemid 47555018)
11. Haller K, Stubenrauch F, Pfister H (1995) Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillo-mavirus type 5 in benign lesions. Virology 214:245-255
12. Hepp KD (1995) Food consumption habits in Germany-the clinician's point of view. Metabolism 44:14-17
13. Heseker H, Hartmann S, Kubler W et al. (1995) An epidemiologic study of food consumption habits in Germany. Metabolism 44:10-13
14. Jablonska S, Majewski S, Obalek S et al. (1997) Cutaneous warts. Clin Dermatol 15:309-319
15. Jablonska S, Orth G, Jarzabek-Chorzelska M et al. (1979) Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus? J Invest Dermatol 72:114-119
16. Karagas MR, Nelson HH, Sehr P et al. (2006) Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 98:389-395
17. Keresztes G, Mutai H, Heller S (2003) TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 4:24
18. Kjaerheim K, Roe OD, Waterboer T et al. (2007) Absence of SV40 antibodies or DNA fragments in prediagnostic mesothelioma serum samples. Int J Cancer 120:2459-2465
19. Kurima K, Yang Y, Sorber K et al. (2003) Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 82:300-308
20. Lazarczyk M, Cassonnet P, Pons C et al. (2009) The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 73:348-370
21. Lazarczyk M, Pons C, Mendoza JA et al. (2008) Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205:35-42
22. Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36:659-85; quiz 686-688
23. Michael KM, Waterboer T, Sehr P et al. (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4:e1000091
24. Michel A, Waterboer T, Nicklas W et al. (2009) Helicobacter pylori multiplex serology. Helicobacter 14:525-535
25. Nonnenmacher M, Salmon J, Jacob Y et al. (2006) Cottontail rabbit papillomavirus E8 protein is essential for wart formation and provides new insights into viral pathogenesis. J Virol 80:4890-4900
26. Orth G (1987) Epidermodysplasia verruciformis. In: The Papovaviridae: The Papillomaviruses (Salzman NP, Howley PM, eds). Plenum Publishing Corp: New York, NY, 199-243
27. Orth G (2006) Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin Immunol 18:362-374
28. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044
29. Patel AS, Karagas MR, Pawlita M et al. (2008) Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study. Int J Cancer 122:2377-2379
30. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31:52-56
31. Pfister H, zur Hausen H (1978) Characterization of proteins of human papilloma viruses (HPV) and antibody response to HPV 1. Med Microbiol Immunol 166:13-19 (Pubitemid 9049957)
32. Purdie KJ, Surentheran T, Sterling JC et al. (2005) Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosup-pressed and immunocompetent individuals. J Invest Dermatol 125:98-107
33. Ramoz N, Rueda LA, Bouadjar B et al. (1999) A susceptibility locus for epidermodysplasia verruciformis, an abnormal predisposition to infection with the oncogenic human papillomavirus type 5, maps to chromosome 17qter in a region containing a psoriasis locus. J Invest Dermatol 112:259-263
34. Ramoz N, Rueda LA, Bouadjar B et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579-581
35. Ramoz N, Taieb A, Rueda LA et al. (2000) Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25. J Invest Dermatol 114:1148-1153
36. Sehr P, Muller M, Hopfl R et al. (2002) HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods 106:61-70
37. Sehr P, Zumbach K, Pawlita M (2001) A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. J Immunol Methods 253:153-162
38. Stark S, Petridis AK, Ghim SJ et al. (1998) Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 111:696-701
39. Steger G, Olszewsky M, Stockfleth E et al. (1990) Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol 64:4399-4406
40. Waterboer T, Neale R, Michael KM et al. (2009) Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia. J Gen Virol 90:1986-1998
41. Waterboer T, Sehr P, Michael KM et al. (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transfer-ase fusion proteins. Clin Chem 51:1845-1853
42. Waterboer T, Sehr P, Pawlita M (2006) Suppression of non-specific binding in serological Luminex assays. J Immunol Methods 309:200-204
43. Weissenborn SJ, De Koning MN, Wieland U et al. (2009) Intrafamilial transmission and family-specific spectra of cutaneous betapapilloma-viruses. J Virol 83:811-816
44. Weissenborn SJ, Nindl I, Purdie K et al. (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 125:93-97
45. Yutsudo M, Hakura A (1987) Human papillomavirus type 17 transcripts expressed in skin carcinoma tissue of a patient with epidermodysplasia verruciformis. Int J Cancer 39:586-589
46. Zavattaro E, Azzimonti B, Mondini M et al. (2008) Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol 128:732-735
47. zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342-350